Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001415889-25-021669·IN8BIO, INC.
Schedule 13G ownership disclosure
IN8bio, Inc.
Common Stock, $0.0001 Par Value Per Share · CUSIP: 45674E208
Event date: 2025-06-30
- Filing-level shares
- 107,416.00
- Percent of class
- 2.6%
- Transcend Partners Opportunity Fund LLC
Shares: 107,416.00 · Class: 2.6%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001415889-25-021669
- Form type
- SCHEDULE 13G/A
- Filer
- IN8BIO, INC.
- CIK
- CIK 1740279
- Filed
- Aug 13, 2025
- Reporting period
- Jun 30, 2025
- Description
- Schedule 13G beneficial ownership